109:. LDH reduces NAD to NADH which elicits a colour change by interaction with a specific probe. Protease biomarkers have been identified that allow researchers to measure relative numbers of live and dead cells within the same cell population. The live-cell protease is only active in cells that have a healthy cell membrane, and loses activity once the cell is compromised and the protease is exposed to the external environment. The dead-cell protease cannot cross the cell membrane, and can only be measured in culture media after cells have lost their membrane integrity.
100:
are normally excluded from the inside of healthy cells; however, if the cell membrane has been compromised, they freely cross the membrane and stain intracellular components. Alternatively, membrane integrity can be assessed by monitoring the passage of substances that are normally sequestered inside
73:
Cells undergoing necrosis typically exhibit rapid swelling, lose membrane integrity, shut down metabolism, and release their contents into the environment. Cells that undergo rapid necrosis in vitro do not have sufficient time or energy to activate apoptotic machinery and will not express apoptotic
87:
Cytotoxicity assays are widely used by the pharmaceutical industry to screen for cytotoxicity in compound libraries. Researchers can either look for cytotoxic compounds, if they are interested in developing a therapeutic that targets rapidly dividing cancer cells, for instance; or they can screen
116:) or with 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT), which yields a water-soluble product, or the MTS assay. This assay measures the reducing potential of the cell using a colorimetric reaction. Viable cells will reduce the MTS reagent to a colored
78:
of the cell, cytoplasmic shrinkage, nuclear condensation and cleavage of DNA into regularly sized fragments. Cells in culture that are undergoing apoptosis eventually undergo secondary necrosis. They will shut down metabolism, lose membrane integrity and lyse.
146:
Suitable assays can be combined and performed sequentially on the same cells in order to reduce assay-specific false positive or false negative results. A possible combination is LDH-XTT-NR (Neutral red assay)-SRB which is also available in a kit format.
194:
contain cytotoxic drugs, whose purpose is interfering with the cell division. These drugs cannot distinguish between normal and malignant cells, but they inhibit the overall process of cell division with the purpose to kill the cancers before the hosts.
150:
A label-free approach to follow the cytotoxic response of adherent animal cells in real-time is based on electric impedance measurements when the cells are grown on gold-film electrodes. This technology is referred to as
91:
Assessing cell membrane integrity is one of the most common ways to measure cell viability and cytotoxic effects. Compounds that have cytotoxic effects often compromise cell membrane integrity. Vital dyes, such as
378:
Decker T, Lohmann-Matthes ML (November 1988). "A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity".
414:
Niles AL, Moravec RA, Eric
Hesselberth P, Scurria MA, Daily WJ, Riss TL (July 2007). "A homogeneous assay to measure live and dead cells in the same sample by detecting different protease markers".
30:. Examples of toxic agents are toxic metals, toxic chemicals, microbe neurotoxins, radiation particles and even specific neurotransmitters when the system is out of balance. Also some types of
294:
Riss TL, Moravec RA (February 2004). "Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays".
726:
608:
203:
155:(ECIS). Label-free real-time techniques provide the kinetics of the cytotoxic response rather than just a snapshot like many colorimetric endpoint assays.
66:. The cells can stop actively growing and dividing (a decrease in cell viability), or the cells can activate a genetic program of controlled cell death (
152:
124:. In addition to using dyes to indicate the redox potential of cells in order to monitor their viability, researchers have developed assays that use
702:
182:
methods have been suggested. An independent comparison of these methods has been done within the "Toxicology in the 21st century" project.
88:"hits" from initial high-throughput drug screens for unwanted cytotoxic effects before investing in their development as a pharmaceutical.
215:
128:
content as a marker of viability. Such ATP-based assays include bioluminescent assays in which ATP is the limiting reagent for the
551:"Cytotoxic Drug Dispersal, Cytotoxic Safety, and Cytotoxic Waste Management: Practices and Proposed India-specific Guidelines"
260:
255:
265:
170:
A highly important topic is the prediction of cytotoxicity of chemical compounds based on previous measurements, i.e.
756:
74:
markers. Apoptosis is characterized by well defined cytological and molecular events including a change in the
112:
Cytotoxicity can also be monitored using 3-(4, 5-Dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium bromide (
214:. Lymphocyte-mediated cytotoxicity, on the other hand, does not have to be mediated by antibodies; nor does
125:
602:
243:
102:
492:
Easty, A.C.; Coakley, N.; Cheng, R.; Cividino, M.; Savage, P.; Tozer, R.; White, R.E. (February 2015).
58:
Treating cells with the cytotoxic compound can result in a variety of prognoses. The cells may undergo
631:
43:
777:
772:
238:
708:
655:
474:
360:
106:
698:
647:
590:
572:
531:
513:
466:
431:
396:
352:
311:
219:
179:
690:
639:
580:
562:
521:
505:
458:
423:
388:
342:
303:
233:
159:
140:
136:
97:
75:
673:
162:, is often marked with a symbol that consists of a capital letter "C" inside a triangle.
635:
120:
product. A similar redox-based assay has also been developed using the fluorescent dye,
585:
550:
526:
493:
449:
Fan F, Wood KV (February 2007). "Bioluminescent assays for high-throughput screening".
191:
35:
27:
752:
766:
392:
364:
712:
659:
478:
270:
93:
567:
307:
694:
643:
226:
207:
129:
63:
576:
517:
427:
171:
121:
113:
67:
651:
594:
535:
470:
435:
356:
347:
330:
315:
400:
462:
211:
117:
59:
23:
509:
331:"Cytotoxic Activity of Herbal Medicines as Assessed in Vitro: A Review"
62:, in which they lose membrane integrity and die rapidly as a result of
31:
622:
Dearden, J. C. (2003). "In silico prediction of drug toxicity".
175:
329:
Gavanji S, Bakhtari A, Famurewa AC, Othman EM (January 2023).
158:
Material that has been determined as cytotoxic, typically
494:"Safe handling of cytotoxics: guideline recommendations"
674:
https://tripod.nih.gov/tox21/challenge/leaderboard.jsp
206:(ADCC) describes the cell-killing ability of certain
210:, which requires the target cell being marked by an
555:Indian Journal of Medical and Paediatric Oncology
672:"Toxicology in the 21st century Data Challenge"
549:Capoor, Malini R; Bhowmik, Kumar Tapas (2017).
204:Antibody-dependent cell-mediated cytotoxicity
8:
607:: CS1 maint: DOI inactive as of July 2024 (
727:"How Is Chemotherapy Used to Treat Cancer?"
624:Journal of Computer-aided Molecular Design
755:at the U.S. National Library of Medicine
584:
566:
525:
346:
153:electric cell-substrate impedance sensing
135:Cytotoxicity can also be measured by the
289:
287:
285:
281:
600:
7:
687:Cancer Chemotherapy: an Introduction
101:cells to the outside. One molecule,
105:(LDH), is commonly measured using
14:
216:complement-dependent cytotoxicity
218:(CDC), which is mediated by the
174:testing. For this purpose many
16:Quality of being toxic to cells
1:
256:Antireticular Cytotoxic Serum
393:10.1016/0022-1759(88)90310-9
335:Chemistry & Biodiversity
266:Membrane vesicle trafficking
139:(SRB) assay, WST assay and
794:
568:10.4103/ijmpo.ijmpo_174_16
308:10.1089/154065804322966315
225:Three groups of cytotoxic
695:10.1007/978-1-4471-1686-8
685:Priestman, T. J. (1989).
261:Host–pathogen interaction
757:Medical Subject Headings
428:10.1016/j.ab.2007.04.007
22:is the quality of being
644:10.1023/A:1025361621494
571:(inactive 2024-07-11).
451:Assay Drug Dev Technol
348:10.1002/cbdv.202201098
296:Assay Drug Dev Technol
244:Natural killer T cells
50:) are toxic to cells.
103:lactate dehydrogenase
463:10.1089/adt.2006.053
239:Natural killer cells
44:brown recluse spider
636:2003JCAMD..17..119D
381:J. Immunol. Methods
229:are distinguished:
510:10.3747/co.21.2151
48:Loxosceles reclusa
704:978-3-540-19551-1
234:Cytotoxic T cells
220:complement system
180:virtual screening
785:
741:
740:
738:
737:
723:
717:
716:
682:
676:
670:
664:
663:
630:(2–4): 119–127.
619:
613:
612:
606:
598:
588:
570:
546:
540:
539:
529:
498:Current Oncology
489:
483:
482:
446:
440:
439:
411:
405:
404:
375:
369:
368:
350:
326:
320:
319:
291:
160:biomedical waste
141:clonogenic assay
137:sulforhodamine B
98:propidium iodide
76:refractive index
34:, e.g. from the
793:
792:
788:
787:
786:
784:
783:
782:
763:
762:
749:
744:
735:
733:
725:
724:
720:
705:
684:
683:
679:
671:
667:
621:
620:
616:
599:
548:
547:
543:
491:
490:
486:
448:
447:
443:
413:
412:
408:
377:
376:
372:
328:
327:
323:
293:
292:
283:
279:
252:
201:
188:
168:
85:
56:
54:Cell physiology
17:
12:
11:
5:
791:
789:
781:
780:
775:
765:
764:
761:
760:
748:
747:External links
745:
743:
742:
731:www.cancer.org
718:
703:
677:
665:
614:
561:(2): 190–197.
541:
504:(1): e27–e37.
484:
441:
422:(2): 197–206.
406:
370:
321:
280:
278:
275:
274:
273:
268:
263:
258:
251:
248:
247:
246:
241:
236:
200:
197:
192:chemotherapies
187:
184:
167:
164:
84:
81:
55:
52:
40:Bitis arietans
15:
13:
10:
9:
6:
4:
3:
2:
790:
779:
776:
774:
771:
770:
768:
758:
754:
751:
750:
746:
732:
728:
722:
719:
714:
710:
706:
700:
696:
692:
688:
681:
678:
675:
669:
666:
661:
657:
653:
649:
645:
641:
637:
633:
629:
625:
618:
615:
610:
604:
596:
592:
587:
582:
578:
574:
569:
564:
560:
556:
552:
545:
542:
537:
533:
528:
523:
519:
515:
511:
507:
503:
499:
495:
488:
485:
480:
476:
472:
468:
464:
460:
457:(1): 127–36.
456:
452:
445:
442:
437:
433:
429:
425:
421:
417:
416:Anal. Biochem
410:
407:
402:
398:
394:
390:
386:
382:
374:
371:
366:
362:
358:
354:
349:
344:
340:
336:
332:
325:
322:
317:
313:
309:
305:
301:
297:
290:
288:
286:
282:
276:
272:
269:
267:
264:
262:
259:
257:
254:
253:
249:
245:
242:
240:
237:
235:
232:
231:
230:
228:
223:
221:
217:
213:
209:
205:
199:Immune system
198:
196:
193:
185:
183:
181:
177:
173:
165:
163:
161:
156:
154:
148:
144:
142:
138:
133:
131:
127:
123:
119:
115:
110:
108:
104:
99:
95:
89:
82:
80:
77:
71:
69:
65:
61:
53:
51:
49:
45:
41:
37:
33:
29:
25:
21:
734:. Retrieved
730:
721:
686:
680:
668:
627:
623:
617:
603:cite journal
558:
554:
544:
501:
497:
487:
454:
450:
444:
419:
415:
409:
384:
380:
373:
338:
334:
324:
302:(1): 51–62.
299:
295:
271:Snake toxins
224:
202:
189:
169:
157:
149:
145:
134:
111:
90:
86:
72:
57:
47:
39:
20:Cytotoxicity
19:
18:
387:(1): 61–9.
341:(2): 3–27.
227:lymphocytes
208:lymphocytes
94:trypan blue
83:Measurement
778:Immunology
773:Toxicology
767:Categories
753:Cytotoxins
736:2021-06-28
277:References
166:Prediction
132:reaction.
130:luciferase
64:cell lysis
36:puff adder
577:0971-5851
518:1198-0052
365:255473013
172:in-silico
122:resazurin
107:LDH assay
68:apoptosis
713:20058092
660:21518449
652:13677480
595:28900329
536:25684994
479:10261888
471:17355205
436:17512890
357:36595710
316:15090210
250:See also
212:antibody
118:formazan
60:necrosis
632:Bibcode
586:5582558
527:4324350
401:3192948
186:Cancers
759:(MeSH)
711:
701:
658:
650:
593:
583:
575:
534:
524:
516:
477:
469:
434:
399:
363:
355:
314:
709:S2CID
656:S2CID
475:S2CID
361:S2CID
190:Some
42:) or
32:venom
28:cells
24:toxic
699:ISBN
648:PMID
609:link
591:PMID
573:ISSN
532:PMID
514:ISSN
467:PMID
432:PMID
397:PMID
353:PMID
312:PMID
178:and
176:QSAR
691:doi
640:doi
581:PMC
563:doi
522:PMC
506:doi
459:doi
424:doi
420:366
389:doi
385:115
343:doi
304:doi
126:ATP
114:MTT
96:or
70:).
26:to
769::
729:.
707:.
697:.
689:.
654:.
646:.
638:.
628:17
626:.
605:}}
601:{{
589:.
579:.
559:38
557:.
553:.
530:.
520:.
512:.
502:22
500:.
496:.
473:.
465:.
453:.
430:.
418:.
395:.
383:.
359:.
351:.
339:20
337:.
333:.
310:.
298:.
284:^
222:.
143:.
739:.
715:.
693::
662:.
642::
634::
611:)
597:.
565::
538:.
508::
481:.
461::
455:5
438:.
426::
403:.
391::
367:.
345::
318:.
306::
300:2
46:(
38:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.